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ABSTRACT 
 
We developed multi-contrast photoacoustic microscopy (PAM) for in vivo anatomical, functional, metabolic, and 
molecular imaging. This technical innovation enables comprehensive understanding of the tumor microenvironment. 
With multi-contrast PAM, we longitudinally determined tumor vascular anatomy, blood flow, oxygen saturation of 
hemoglobin, and oxygen extraction fraction. 
 
Keywords: Optical-resolution photoacoustic microscopy, vascular anatomy, hemoglobin oxygen saturation, oxygen 
extraction fraction, tumor microenvironment. 
 
  
INTRODUCTION 
 
To date, photoacoustic imaging of anatomical (1), functional (2), metabolic (3), molecular (4), and genetic (5) contrasts 
has been demonstrated in vivo. However, each individual contrast can hardly provide a comprehensive characterization 
of the complex biological system. In cancer research, for instance, vascular anatomy, blood oxygenation, and the 
metabolic rate of oxygen are highly desired to study neovascularization, tumor hypoxia, and tumor hypermetabolism, 
respectively.  In some disease models, exogenous molecular biomarkers are needed to visualize non-absorbing 
molecules (6). By integrating the aforementioned multiple photoacoustic contrasts into a single microscopy platform, we 
have developed multi-contrast photoacoustic microscopy (PAM). Its potential application includes vascular and 
metabolic signaling pathways, neurovascular and neurometabolic coupling, in vivo drug screening, as well as therapy 
design and management. 
 
 
METHODS AND MATERIALS  
 
The multi-contrast imaging platform was developed based on our second-generation optical-resolution PAM (Fig. 1) (7). 
The object to be imaged is irradiated with a short-pulsed laser beam generated by a wavelength-tunable laser system, 
consisting of an Nd:YLF pump laser and a dye laser. Wideband ultrasonic waves are induced as a result of transient 
thermo-elastic expansion due to the laser excitation, and then detected by a high-frequency ultrasonic transducer. To 
maximize the sensitivity, the optical illumination and the ultrasonic detection in our system are configured confocally by 
an acoustic-optical beam combiner, where a right-angle prism and a rhomboid prism form a cube with a thin layer of 
silicone oil in between. This novel design offers high acoustic detection sensitivity. A microscopic objective lens is 
employed to achieve nearly diffraction-limited optical resolution (~2.6 µm in clear media).  
 
The wavelength-tunable laser allows exciting various endogenous chromophores (Fig. 2A), and exogenous molecular 
biomarkers (Fig. 2C). The diffraction-limited optical focusing provides a cellular resolution. The two-dimensional 
actuator-based mechanical scanning and steering-mirror-based optical scanning enable wide-field and real-time imaging, 
respectively. Multi-wavelength measurement allows quantifying hemoglobin oxygen saturation (sO2) (Fig. 2B) (8). The 
photoacoustic Doppler effect reveals blood flow (9). Based on the anatomical and functional information, oxygen 
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extraction fraction (OEF) and the metabolic rate of oxygen (MRO2) can be computed (3). Further, powerful vessel 
segmentation analysis allows us to assess the multiple physiological contrasts on a single-vessel basis (10, 11). 
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Fig. 1. Schematic of the multi-contrast PAM system. 
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Fig. 2. Multi-contrast PAM in vivo. The vascular anatomy and function in a mouse ear are shown by the maps of (A) hemoglobin 
concentration (CHb) and (B) sO2, respectively. (C) Molecular imaging of Congo Red dye-labeled cerebral amyloid plaques in an 
Alzheimer’s disease mouse model. 
 
 
RESULTS  
 
Recently, we have applied multi-contrast PAM to longitudinally monitor the regulation of angiogenesis and the tumor 
metabolic microenvironment during spontaneous growth and chemotherapy in a renal carcinoma xenograft (Fig. 3). 
Right after taking the baseline measurements of the vascular anatomy and sO2, renal carcinoma cells were inoculated 
into the mouse ear. Then, the spontaneous tumor growth was monitored for 25 days before a daily RAD001 treatment for 
two weeks. During the tumor growth and treatment, vascular anatomical (i.e., diameter) and functional (i.e., blood flow 
and sO2) information was acquired, based on which OEF was computed. A marked normalization of arterial blood flow 
in response to the 2-week RAD001 treatment was clearly observed, which also implied the normalization of tumor 
oxygen metabolism. 
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Fig. 3. Multi-contrast PAM of the tumor microenvironment during spontaneous growth and chemotherapy. 
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CONCLUSION 
 
We have developed multi-contrast PAM for in vivo imaging of anatomical, functional, metabolic, and molecular 
contrasts at the microscopic level. Its potential has been demonstrated by our recent research on the microenvironmental 
regulation of renal tumor during spontaneous growth and chemotherapy. Future applications of multi-contrast PAM 
include vascular and metabolic signaling pathways, neurovascular and neurometabolic coupling, in vivo drug screening, 
as well as therapy design and management. 
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